Transcatheter heart valves technologies

Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center experience with two cases

Published on 18/01/2024 | Kushimo Oyewole A. 1 et al. | The Egyptian Heart Journal 2024; 76(1): 3 | 10 minute read

Abstract Background The performance of transcatheter aortic valve replacement (TAVR) in patients with pre-existing prosthetic mitral valves is technically challenging

Transcatheter heart valves technologies

Secondary retensioning of a tether-based device for transapical transcatheter mitral valve implantation

Published on 04/01/2024 | Martin Beyer et al. | European journal of cardio-thoracic surgery 2023; aop: 10.1093/ejcts/ezad430 | 0 minute read

Transcatheter heart valves technologies

Percutaneous coronary intervention: Before, after, or during TAVR?

Published on 04/01/2024 | Ivan HansonMD et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30941 | 5 minute read

Abstract Key points Decisions surrounding if, and when, to perform coronary revascularization in patients undergoing trans‐catheter aortic valve replacement (TAVR)

Transcatheter heart valves technologies

Evaluation of cerebrovascular events via retinal angiography during transcatheter aortic valve implantation

Published on 21/12/2023 | Qian Henna a Piuhola Jarkko a Kiviniemi Heidi a b Niemelä Matti a Hautala Nina c Junttila Juhani a a Research Unit of Internal Medicine et al. | Scandinavian Cardiovascular Journal 2023; 57(1): | 0 minute read

Transcatheter heart valves technologies

Transcatheter mitral valve replacement with Mi‐thos system: First‐in‐human experience

Published on 21/12/2023 | Ye YangMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30926 | 13 minute read

Abstract Background Transcatheter mitral valve replacement (TMVR) has become an alternative for high‐risk patients with severe mitral regurgitation (MR). The

Transcatheter heart valves technologies

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation

Published on 07/12/2023 | Roberto Scarsini 1 et al. | Heart 2023; aop:10.1136/heartjnl-2023-323461 | 21 minute read

Abstract Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter

Transcatheter heart valves technologies

Unusual cause of myocardial infarction following transcatheter aortic valve replacement

Published on 07/12/2023 | NeerajShah 1 et al. | Clinical case reports 2023; 11(11): 8091 | 9 minute read

Key Clinical Message Left coronary artery embolism from aortic valve leaflet tissue mass is a rare but potentially life‐threatening complication

Transcatheter heart valves technologies

Bilateral multiple stroke, left upper extremity ischemia, and transient complete atrioventricular block in transcatheter aortic valve implantation: a case report

Published on 16/11/2023 | Mitsuta Yuki 1 et al. | JA Clinical Reports 2023; 9(1): 76 | 10 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgery. However, there is a risk of surgical manipulation

Transcatheter heart valves technologies

Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention

Published on 16/11/2023 | Lyle DershowitzMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30850 | 19 minute read

Abstract Aims Characterize the impact of residual tricuspid regurgitation (TR) on right ventricle (RV) remodeling and clinical outcomes after transcatheter

Transcatheter heart valves technologies

Association between perioperative statin treatment and short-term clinical outcomes following transcatheter aortic valve implantation: a retrospective cohort study

Published on 02/11/2023 | Geert Lefeber 1 et al. | Open Heart 2023; 10(2): e002348 | 17 minute read

Abstract Background Studies have found statin treatment to be associated with improved 1-year survival after transcatheter aortic valve implantation (TAVI),

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.